Park KH - Search Results

1

In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.

Lee CT, Lee YJ, Kwon SY, Lee J, Kim KI, Park KH, Kang JH, Yoo CG, Kim YW, Han SK, Chung JK, Shim YS, Curiel DT, Carbone DP. Lee CT, et al. Among authors: park kh. Cancer Res. 2006 Jan 1;66(1):372-7. doi: 10.1158/0008-5472.CAN-05-1515. Cancer Res. 2006. PMID: 16397251

2

Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.

Lee CT, Park KH, Adachi Y, Seol JY, Yoo CG, Kim YW, Han SK, Shim YS, Coffee K, Dikov MM, Carbone DP. Lee CT, et al. Among authors: park kh. Cancer Gene Ther. 2003 Jan;10(1):57-63. doi: 10.1038/sj.cgt.7700524. Cancer Gene Ther. 2003. PMID: 12489029

3

Inhibitory effect of adenovirus-uteroglobin transduction on the growth of lung cancer cell lines.

Lee JC, Park KH, Han SJ, Yoo CG, Lee CT, Han SK, Shim YS, Kim YW. Lee JC, et al. Among authors: park kh. Cancer Gene Ther. 2003 Apr;10(4):287-93. doi: 10.1038/sj.cgt.7700569. Cancer Gene Ther. 2003. PMID: 12679801

4

Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect.

Seol JY, Park KH, Hwang CI, Park WY, Yoo CG, Kim YW, Han SK, Shim YS, Lee CT. Seol JY, et al. Among authors: park kh, park wy. Cancer Gene Ther. 2003 Jul;10(7):540-8. doi: 10.1038/sj.cgt.7700597. Cancer Gene Ther. 2003. PMID: 12833134

5

The effect of adenovirus-IkappaBalpha transduction on the chemosensitivity of lung cancer cell line with resistance to cis-diamminedichloroplatinum(II)(cisplatin) and doxorubicin(adriamycin).

Lee CT, Seol JY, Lee SY, Park KH, Han SJ, Yoo CG, Han SK, Shim YS, Kim YW. Lee CT, et al. Among authors: park kh. Lung Cancer. 2003 Aug;41(2):199-206. doi: 10.1016/s0169-5002(03)00227-7. Lung Cancer. 2003. PMID: 12871783

6

Application of p27 gene therapy for human malignant glioma potentiated by using mutant p27.

Park KH, Lee J, Yoo CG, Kim YW, Han SK, Shim YS, Kim SK, Wang KC, Cho BK, Lee CT. Park KH, et al. J Neurosurg. 2004 Sep;101(3):505-10. doi: 10.3171/jns.2004.101.3.0505. J Neurosurg. 2004. PMID: 15352609

7

Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.

Lee CT, Park KH, Yanagisawa K, Adachi Y, Ohm JE, Nadaf S, Dikov MM, Curiel DT, Carbone DP. Lee CT, et al. Among authors: park kh. Cancer Res. 2004 Sep 15;64(18):6660-5. doi: 10.1158/0008-5472.CAN-04-1200. Cancer Res. 2004. PMID: 15374981

8

Gene therapy with GM-CSF, interleukin-4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancer.

Park KH, Kim G, Jang SH, Kim CH, Kwon SY, Yoo CG, Kim YW, Kwon HC, Kim CM, Han SK, Shim YS, Lee CT. Park KH, et al. Anticancer Res. 2003 Mar-Apr;23(2B):1559-64. Anticancer Res. 2003. PMID: 12828142

9

Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.

Biktasova AK, Dudimah DF, Uzhachenko RV, Park K, Akhter A, Arasada RR, Evans JV, Novitskiy SV, Tchekneva EE, Carbone DP, Shanker A, Dikov MM. Biktasova AK, et al. Cancer Res. 2015 Nov 15;75(22):4728-41. doi: 10.1158/0008-5472.CAN-14-1154. Epub 2015 Sep 24. Cancer Res. 2015. PMID: 26404003 Free PMC article.

10

A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma.

Kaufman JM, Yamada T, Park K, Timmers CD, Amann JM, Carbone DP. Kaufman JM, et al. Cancer Res. 2017 Jan 1;77(1):153-163. doi: 10.1158/0008-5472.CAN-16-1639. Epub 2016 Nov 7. Cancer Res. 2017. PMID: 27821489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,607 results

Search Page

Filters